The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
eMudhra shares crash another 4%, down 40% in 3 sessions. What’s behind this free fall?
eMudhra will exit its global SSL/TLS certificate business following a security incident involving compromised private keys linked to eight intermediate Certificate Authority certificates. The segment
October 23, 2026